September 27, 2024
FDA & Government News
September 26, 2024
FDA Approves Osimertinib in Stage III NSCLC After Chemoradiotherapy
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 23, 2024
Florida’s New Covid Booster Guidance Is Straight-Up Misinformation
KFF Health News
Advertisement
Recommendations
Advertisement